Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

134.58
Delayed Data
As of 4:00pm ET
 -1.29 / -0.95%
Today’s Change
102.10
Today|||52-Week Range
149.34
+12.53%
Year-to-Date

Today’s Trading

Previous close135.87
Today’s open136.27
Day’s range133.80 - 136.87
Volume1,132,168
Average volume (3 months)1,799,190
Market cap$27.3B
Data as of 4:00pm ET, 07/16/2018

Growth & Valuation

Earnings growth (last year)+11.93%
Earnings growth (this year)+18.62%
Earnings growth (next 5 years)+15.70%
Revenue growth (last year)+17.32%
P/E ratio57.8
Price/Sales7.63
Price/Book3.07

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc-1.56-1.81%
BAXBaxter International...-0.77-1.03%
INCYIncyte Corp-0.08-0.11%
VRTXVertex Pharmaceutica...+0.72+0.40%
Data as of 4:03pm ET, 07/16/2018

Financials

Next reporting dateJuly 26, 2018
EPS forecast (this quarter)$1.69
Annual revenue (last year)$3.5B
Annual profit (last year)$443.3M
Net profit margin12.55%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ludwig N. Hantson
Chief Financial Officer &
Executive Vice President
Paul J. Clancy
Corporate headquarters
New Haven, Connecticut

Forecasts